Stockreport

KalVista: Prophylaxis Is Shrinking The Acute HAE TAM [Seeking Alpha]

KalVista Pharmaceuticals, Inc.  (KALV) 
Last kalvista pharmaceuticals, inc. earnings: 3/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF Ekterly's commercial debut faces headwinds from new, highly effective prophylactic competitors, shrinking the addressable market for on-demand HAE treatments like KALV' [Read more]